{"id":"W4407288611","doi":"10.1136/jitc-2024-009890","title":"Real-world outcomes with tisagenlecleucel in aggressive B-cell lymphoma: subgroup analyses from the CIBMTR registry","year":2025,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Juravinski Hospital","funders":"Iovance Biotherapeutics; Janssen Research and Development; National Institute of Allergy and Infectious Diseases; National Cancer Institute; Office of Naval Research; National Heart, Lung, and Blood Institute; bluebird bio; Pharmacyclics; Takeda Oncology; Legend Biotech; U.S. Navy; Adaptive Biotechnologies; Health Resources and Services Administration; National Institutes of Health; CytoSen Therapeutics; MorphoSys; CareDx; BeiGene; Swedish Orphan Biovitrum; Astellas Pharma; CSL Behring; Kyowa Kirin Pharmaceutical Development; Atara Biotherapeutics; Vertex Pharmaceuticals; Anthem Foundation; GlaxoSmithKline; Kiadis Pharma; Sanofi; TG Therapeutics; Medac; Jazz Pharmaceuticals; Omeros Corporation; U.S. Department of Defense; Medical College of Wisconsin; StemCyte; AbbVie; Actinium Pharmaceuticals; Gilead Sciences; Stanford University; National Marrow Donor Program; Mallinckrodt Pharmaceuticals; Merck; Bristol-Myers Squibb; AstraZeneca; Astellas Pharma US; Be The Match Foundation; Novartis Pharmaceuticals Corporation; Dana-Farber Cancer Institute; Allogene Therapeutics; Incyte; Pfizer; Amgen; Boston Children's Hospital; HistoGenetics","keywords":"Medicine; Cytokine release syndrome; Fludarabine; Internal medicine; Oncology; Hematopoietic stem cell transplantation; Diffuse large B-cell lymphoma; Salvage therapy; Cohort; Lymphoma; Transplantation; Chimeric antigen receptor; Immunotherapy; Chemotherapy; Cancer; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006224303,0.000472587,0.001175912,0.002514803,0.0003212108,0.001515217,0.0008797982,0.0004991129,0.002055341],"category_scores_gemma":[0.01111477,0.0003048149,0.003230678,0.003948549,0.0002992735,0.0008479168,0.001395246,0.0006896115,0.0004396358],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009018927,"about_ca_system_score_gemma":0.000814334,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003958053,"about_ca_topic_score_gemma":0.005978825,"domain_scores_codex":[0.9940352,0.0021934,0.001252594,0.001015838,0.0009102368,0.0005928229],"domain_scores_gemma":[0.9900084,0.002096562,0.004926514,0.001772348,0.0007055574,0.0004906253],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004223731,0.00006473072,0.9835556,0.0002917204,0.004303541,0.0002045032,0.0001601306,0.000549239,0.0002015311,0.00009584396,0.001377744,0.00497161],"study_design_scores_gemma":[0.0003949298,0.0004599104,0.9924939,0.00009085894,0.00261847,0.0005765003,0.0004211285,0.0008045787,0.0001427314,0.0001267918,0.001837808,0.00003240033],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9834639,0.002202477,0.0003978655,0.0001166878,0.00002255446,0.0001812434,0.01222362,0.0000261666,0.001365517],"genre_scores_gemma":[0.9891149,0.0002897811,0.000166023,0.0000601326,0.00002678725,0.0001873487,0.01000017,0.00002248985,0.0001324342],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006224303,"threshold_uncertainty_score":0.03291768,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04027750660366552,"score_gpt":0.41093005155627,"score_spread":0.3706525449526045,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}